Webinar

Kidney as a Target: The Important Role of SLCs (Sodium Linked Co-Transporters)

Now Available On-Demand

Although the primary focus of the pharmaceutical industry has been identifying the mechanisms of drug elimination and potential drug liability, there is now an increasing focus on the kidney as a therapeutic target. In this webinar, the role of a number of strategies to actively target therapeutics to the proximal tubule to regulate expression of proximal tubule transport proteins or modify gene expression will be explored. The webinar will review a number of case studies on the interactions of a range of small molecules, peptides and biologics (gene therapies) with various SLC families generated in the highly differentiated, near-physiology aProximate™ primary proximal tubule platform.

Attend this webinar to:
  • Gain understanding of the utility of the aProximate™ platform as a model of the proximal tubule
  • Hear an up to date review of the proximal tubule as a therapeutic drug target
  • Gain an understanding of targeted delivery of small molecules, peptides and biologics (gene therapy) to the proximal tubule

Speaker Information:

WebinarSpeakerImage-(003)-Jul-30-2021-10-53-36-20-AM

Dr. Colin Brown

Chief Innovations Officer

Newcells Biotech

 

 

Attend this webinar to:

  • Gain understanding of the utility of the aProximate™ platform as a model of the proximal tubule
  • Hear an up to date review of the proximal tubule as a therapeutic drug target
  • Gain an understanding of targeted delivery of small molecules, peptides and biologics (gene therapy) to the proximal tubule

Register for FREE Now!